Kinnate Biopharma Inc
Change company Symbol lookup
Select an option...
KNTE Kinnate Biopharma Inc
JPM-K JPMorgan Chase & Co
KLAC KLA Corp
CNVY Convey Health Solutions Holdings Inc
EBAY eBay Inc
PRLX Parallax Health Sciences Inc
AXS AXIS Capital Holdings Ltd
SPNS Sapiens International Corporation NV
SPCE Virgin Galactic Holdings Inc
BBLG Bone Biologics Corp
Go

Health Care : Biotechnology |
Company profile

Kinnate Biopharma Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers. Its products candidate include KIN-2787, KIN-3248 and KIN004. The KIN-2787 is a small molecule kinase inhibitor targeting specific classes of BRAF kinase alterations that characterize subsets of lung cancer, melanoma and other solid tumors. The Company has initiated a Phase I clinical trial for KIN-2787 (KN-8701). KIN-3248 is a small-molecule kinase inhibitor targeting cancer-associated alterations in FGFR2 and FGFR3 genes. KIN-3248 address the initial alteration and clinically-observed and predicted mutations in FGFR2 fusion gene-positive intrahepatic cholangiocarcinoma and FGFR3-altered ulcerative colitis. It is also developing a CDK12 inhibitor candidate to target the treatment of ovarian carcinoma, metastatic castration-resistant prostate cancer and triple-negative breast cancer.

Closing Price
$14.81
Day's Change
0.01 (0.07%)
Bid
--
Ask
--
B/A Size
--
Day's High
15.16
Day's Low
14.40
Volume
(Heavy Day)
Volume:
170,150

10-day average volume:
94,439
170,150
  • Prev Close
    14.80
  • Today's Open
    14.80
  • Day's Range
    14.40-15.16
  • Avg Vol (10-day)
    94.4K
  • Last (time)
    4:00p ET 08/09/22
  • Last (size)
    738
  • 52-Wk Range
    7.18 - 26.05
    LowHigh
  • (11/05/21 - 06/01/22)
    106.41%
  • 84.7%
  • Market Cap
    651.3M
  • Shares Outstanding
    44.0M
  • -2.27
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 94.14
  • (% of float 07/15/22)
    9.67

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.